Novartis says buys Ziarco Group to expand skin care portfolio

ZURICH, Dec 16 (Reuters) - Novartis is buying

privately held drugmaker Ziarco Group for an undisclosed sum to

gain access to its investigational eczema medicine, the Swiss

pharmaceutical giant said on Friday.

Read more